Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 683.45 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 862.79 Million by 2027, exhibiting a growth rate (CAGR) of 3.75% during 2022-2027.

Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer’s disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function. 

Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:

The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren’s syndrome, Alzheimer’s diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug type and distribution channel.

Breakup by Type:

  • Artificial Saliva/Saliva Substitutes
  • Salivary Stimulants
     

Breakup by Drug Type:

  • OTC
  • Prescription
     

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Type, Drug Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global xerostomia (dry mouth disease) therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global xerostomia (dry mouth disease) therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Xerostomia (Dry Mouth Disease) Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Artificial Saliva/Saliva Substitutes
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Salivary Stimulants
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Drug Type
    7.1    OTC
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Prescription
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    3M Company
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Biotene (GSK plc)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Parnell Pharmaceuticals Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Quest Products LLC
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Saliwell Ltd
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Sun Pharmaceutical Industries Limited
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio

List of Figures

Figure 1: Global: Xerostomia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2021
Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2021
Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Xerostomia Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Xerostomia Therapeutics Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Xerostomia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 4: Global: Xerostomia Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Xerostomia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Xerostomia Therapeutics Market: Competitive Structure
Table 7: Global: Xerostomia Therapeutics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4